Scoopfeeds — Intelligent news, curated.
Dianthus Therapeutics stock rating maintained at Buy by TD Cowen
business

Dianthus Therapeutics stock rating maintained at Buy by TD Cowen

Investing.com · Jun 10, 2026, 6:25 PM · Also reported by 1 other source

Dianthus Therapeutics stock rating maintained at Buy by TD Cowen

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop